Alphabet’s Isomorphic Labs Secures $2.1 Billion to Accelerate AI-Driven Drug Discovery
Isomorphic Labs, founded by DeepMind co-founder Demis Hassabis, has raised $2.1 billion in a Series B funding round to enhance its AI platform for drug research and push new treatments toward clinical trials.
